In Vivo Detection of Circulating Clots in Patients With Thromboembolism

Status Recruiting

Clinical Trial Summary

Subjects with thromboembolic disease or at high-risk for thromboembolic conditions diagnosed with ultrasound or other standard of care techniques will be recruited to estimate the feasibility of a device to detect in vivo CBCs.

Clinical Trial Description

There are no current gold standards to detect circulating blood clots. The sensitivity of most current methods to detect CBCs is poor when low numbers are present in the host. A novel method of detecting circulating blood clots, PAFC, may improve detection of CBCs and, if so, ultimately may reduce complications related to previously undetected clots. ;

Study Design

Related Conditions & MeSH terms

Thromboembolism

Clinical Trial Details

NCT number	NCT05301348
Study type	Interventional
Source	University of Arkansas
Contact	Sanjeeva Onteddu, MD
Phone	5016865135
Email	sronteddu@uams.edu
Status	Recruiting
Phase	N/A
Start date	July 26, 2023
Completion date	January 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05794165` - Antithrombin to Improve Thromboprophylaxis and Reduce the Incidence of Trauma-Related Venous Thromboembolism	Phase 2
Active, not recruiting	`NCT05563883` - Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
Terminated	`NCT02475187` - Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur Fracture
Recruiting	`NCT00982514` - Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008	N/A
Completed	`NCT01420809` - Special Drug Use Investigation for ARIXTRA® (Fondaparinux) Injection	N/A
Terminated	`NCT00206089` - Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events	Phase 3
Completed	`NCT00014352` - Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer	Phase 2
Completed	`NCT00000614` - Prevention of Recurrent Venous Thromboembolism (PREVENT)	Phase 3
Active, not recruiting	`NCT05656963` - The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKD
Completed	`NCT04719182` - Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19
Completed	`NCT02935751` - Apixaban Discontinuation Prior to Major Surgery
Terminated	`NCT02579122` - REVIparin-BRIDging-in a General Practice Setting in GErmany
Completed	`NCT01696760` - Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology	N/A
Completed	`NCT00986154` - Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).	Phase 3
Terminated	`NCT00662688` - Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer	Phase 3
Completed	`NCT00260988` - A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery	Phase 2/Phase 3
Terminated	`NCT00031837` - Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer	Phase 3
Completed	`NCT03877770` - DVT After Cardiac Procedure
Completed	`NCT00024297` - Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters	N/A
Recruiting	`NCT06118957` - Low Molecular Weight Heparin or no Treatment Following Cesarean Delivery	Phase 2